US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

WallStreetBets

2,551.25

-189.6069-6.92%

Number of Gainers:1

Number of Losers:20

Number of Flat:- -

PE:- -

High:2,744.89

Open:2,740.18

Low:2,544.88

Close:2,740.86

Volume:452.41M

Turnover:26.20B

Market Cap:695.39B

Float Cap:599.69B

Loading ...

Clover Health price target lowered to $3.70 from $4.10 at Canaccord

Flood-Prone U.S. Counties See Net Outflow of Residents for First Time Since 2019

Robinhood Launches ENA

CORRECTED-UPDATE 2-US shutdown sends airlines scrambling as travel chaos looms

Novavax Reports $70 Million Q3 Revenue and Raises 2025 Revenue Framework

CORRECTED-UPDATE 3-Novavax defers profitability target by a year on weak COVID vaccine sales

Geo Group Shares up 3.4% Premarket After Q3 REV Beats Estimates

THOMSON REUTERS

BioCryst Unveils Data Showing ORLADEYO Cuts HAE Attacks in Children in Yearlong Trial

BioCryst Presents New Data at Acaai Highlighting Burden of Hae on Pediatric Patients and Caregivers and Sustained Reduction of Attacks in Children Treated With One Year of Orladeyo® (Berotralstat)

THOMSON REUTERS

Novavax Outlook FY Adjusted Total Revenue USD 1,040-1,060 Million

THOMSON REUTERS

Novavax Outlook FY Adj Total Revenue $1.04 Bln-$1.06 Bln VS Ibes Estimate $1.05 Bln

THOMSON REUTERS

Novavax: Non-Cash Charges for Q3 Were $126 Mln

THOMSON REUTERS

Novavax beats quarterly revenue estimates on milestone payment

Novavax Q3 Revenue $70.4 Mln VS Ibes Estimate $42.1 Mln

THOMSON REUTERS

Robinhood To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Thursday

Cantor Analyst Remains Cautious on Rivian Stock (RIVN) Despite Q3 Beat

Stagwell Shares up 60% Premarket After Co Announces AI Partnership With Palantir, Better-Than-Expected FY Profit Forecast

THOMSON REUTERS

Stagwell Q3 revenue misses estimates

BRIEF-Palantir Technologies And Stagwell Announces Partnership Centered Around An AI-Driven Platform For Marketers

Stagwell Inc. reports net new business of $122 million in third quarter

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4547/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4547","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4547\",,,,,undefined,":{"symbol":"BK4547","market":"US","secType":"PLATE","nameCN":"WallStreetBets","latestPrice":2551.25,"timestamp":1762462799999,"preClose":2740.857,"halted":0,"volume":452405535,"delay":0,"changeRate":-0.069178,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-189.606934,"latestTime":"11-06 16:00:00 EST","open":2740.175,"high":2744.8914,"low":2544.8755,"amount":26196183808.180286,"amplitude":0.072976,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1762477200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":12.499968,"peRate":508.653981,"turnoverRate":0.04589,"increases":1,"decrements":20,"flats":0,"marketCap":695385762064,"floatMarketCap":599687614924},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4547\",,,,,undefined,":{"symbol":"BK4547","high":2744.8914,"amplitude":0.072976,"preClose":2740.857,"low":2544.8755,"pbRate":"12.499968","latestPrice":2551.25,"volume":452405535,"delay":0,"open":2740.175,"prevYearClose":1374.9788,"prevWeekClose":2893.205,"prevMonthClose":2893.205,"prevQuarterClose":2740.7517,"fiveDayClose":2796.9275,"twentyDayClose":2801.266,"sixtyDayClose":2632.043,"secType":"PLATE","market":"US","turnoverRate":0.04589,"peRate":508.653981,"marketCap":695385762064,"floatMarketCap":599687614924,"timestamp":1762462799999,"nameCN":"WallStreetBets"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4547\",,,,undefined,":{"bkCode":"BK4547","up":1,"down":20,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4547\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2581096924","title":"Clover Health price target lowered to $3.70 from $4.10 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2581096924","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581096924?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:38","pubTimestamp":1762436338,"startTime":"0","endTime":"0","summary":"Canaccord lowered the firm’s price target on Clover Health (CLOV) to $3.70 from $4.10 and keeps a Buy rating on the shares. The firm said Clover’s ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clover-health-price-target-lowered-to-3-70-from-4-10-at-canaccord-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clover-health-price-target-lowered-to-3-70-from-4-10-at-canaccord-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLOV","BK4547","BK4154"],"gpt_icon":0},{"id":"2581846096","title":"Flood-Prone U.S. Counties See Net Outflow of Residents for First Time Since 2019","url":"https://stock-news.laohu8.com/highlight/detail?id=2581846096","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581846096?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:31","pubTimestamp":1762435871,"startTime":"0","endTime":"0","summary":"Rocket Companies Inc. has released a new market analysis highlighting a shift in U.S. migration patterns related to flood risk. For the first time since 2019, high-flood-risk counties experienced a net loss of residents, with 29,027 more people moving out than in last year. In contrast, low-flood-risk counties saw a net gain of 35,941 residents, marking the largest increase since 2019. The report notes that factors such as soaring insurance costs, high home prices, and the financial burden of HOA dues and special assessments-especially in Florida-are contributing to the exodus from flood-prone areas. Additionally, climate events like Hurricane Helene in Pinellas County, FL, have forced many homeowners to relocate, often to regions with lower flood risk or out of state entirely. The analysis also points to a decrease in international homebuyers and highlights that affordability and climate concerns are reshaping migration trends in places like Houston and the broader Sun Belt region.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL8kzd8f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RKT","BK4547","BK4195","BK4229"],"gpt_icon":0},{"id":"2581099599","title":"Robinhood Launches ENA","url":"https://stock-news.laohu8.com/highlight/detail?id=2581099599","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581099599?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:25","pubTimestamp":1762435500,"startTime":"0","endTime":"0","summary":"BlockBeats News, November 6th, Robinhood Lists Ethena (ENA).","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_live","url":"https://www.theblockbeats.info//en/flash/319429","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/319429","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["LU1861559042.SGD","BK4127","HOOD","ENA.AU","BK4547","LU1861558580.USD","BK7101","BK4539"],"gpt_icon":0},{"id":"2581093224","title":"CORRECTED-UPDATE 2-US shutdown sends airlines scrambling as travel chaos looms","url":"https://stock-news.laohu8.com/highlight/detail?id=2581093224","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581093224?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:09","pubTimestamp":1762434574,"startTime":"0","endTime":"0","summary":"CORRECTED-UPDATE 2-US shutdown sends airlines scrambling as travel chaos loomsCorrects second bullet to say that airports are facing staffing shortages, not airlines; also fixes formatting in third bulletFlight cuts set to be ordered at 40 busiest U.S. airports due to shutdownAirports face staffing shortages, causing delays and affecting 3.2 million travelersCarriers try to limit disruption ahead of busy Thanksgiving holidayDelta will start reducing flights from FridayBy Shivansh Tiwary","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL4N3WI16P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4500","BK4585","BK4547","BK4588","LU0310800965.SGD","LU1267930227.SGD","AAL","DAL","IE00BFMHRM44.USD","LU0128525689.USD","BK4539","LUV","ULCC","LU0052756011.USD","UAL","BK4008"],"gpt_icon":0},{"id":"2581093628","title":"Novavax Reports $70 Million Q3 Revenue and Raises 2025 Revenue Framework","url":"https://stock-news.laohu8.com/highlight/detail?id=2581093628","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581093628?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:02","pubTimestamp":1762434170,"startTime":"0","endTime":"0","summary":"Novavax Inc. reported its financial results and operational highlights for the third quarter ended September 30, 2025. The company recorded total revenue of $70 million for the quarter. Revenues from its Sanofi partnership reached $48 million in the third quarter, a 33% increase compared to $36 million in the same period last year. Licensing, royalties, and other revenue totaled $57 million, up 33% from $43 million in the prior year quarter. Product sales declined to $13 million from $41 million in the third quarter of 2024, representing a 68% decrease. Nuvaxovid sales were reported at $0, down from $38 million a year earlier. Supply sales increased to $14 million from $3 million in the previous year. Novavax highlighted continued successful execution of its Sanofi partnership, earning $225 million in milestones year-to-date, including $50 million in the fourth quarter of 2025 from marketing authorization transfers for EU and US markets. The company also completed Maryland site consoli","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL7wZcZx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4547","NVAX","BK4139","BK4588","BK4585"],"gpt_icon":0},{"id":"2581936440","title":"CORRECTED-UPDATE 3-Novavax defers profitability target by a year on weak COVID vaccine sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2581936440","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581936440?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:02","pubTimestamp":1762434124,"startTime":"0","endTime":"0","summary":"CORRECTED-UPDATE 3-Novavax defers profitability target by a year on weak COVID vaccine salesCorrects paragraph 2 and third bullet to say prescriptions in the COVID vaccine market dropped 20%, not just","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL4N3WI1DC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4547","BK4568","BK4588","NVAX","BK4139","BK4585"],"gpt_icon":0},{"id":"2581093334","title":"Geo Group Shares up 3.4% Premarket After Q3 REV Beats Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2581093334","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581093334?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:00","pubTimestamp":1762434028,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL4N3WI1DL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4585","BK4165","BK4516","BK4547","BK4084","GEO"],"gpt_icon":0},{"id":"2581093327","title":"BioCryst Unveils Data Showing ORLADEYO Cuts HAE Attacks in Children in Yearlong Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2581093327","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581093327?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:00","pubTimestamp":1762434019,"startTime":"0","endTime":"0","summary":"BioCryst Pharmaceuticals Inc. has announced new data from the ongoing APeX-P clinical trial evaluating ORLADEYO  in pediatric patients with hereditary angioedema  aged 2 to under 12 years. The results, presented at the Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology  in November 2025, show early and sustained reductions in monthly HAE attack rates over one year of treatment with once-daily ORLADEYO oral granules. The company also highlighted findings on the negative psychosocial impact of HAE and emergency care visits on children and their caregivers. A New Drug Application for ORLADEYO oral granules as prophylaxis in this pediatric population is currently under review by the U.S. Food and Drug Administration, with a decision expected by the end of 2025. If approved, ORLADEYO would be the first targeted oral prophylactic therapy for HAE patients aged 2 to under 12 years.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL6Sp6xw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2095319765.USD","BCRX","BK4547","LU0314104364.USD","IE00B64PRP62.GBP","BK4112","BK4588","NDAQ","BK4585","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4139","LU2210149790.SGD"],"gpt_icon":0},{"id":"2581093826","title":"BioCryst Presents New Data at Acaai Highlighting Burden of Hae on Pediatric Patients and Caregivers and Sustained Reduction of Attacks in Children Treated With One Year of Orladeyo® (Berotralstat)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581093826","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581093826?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:00","pubTimestamp":1762434003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nTUA8D6HYL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4547","BCRX","BK4139"],"gpt_icon":0},{"id":"2581093843","title":"Novavax Outlook FY Adjusted Total Revenue USD 1,040-1,060 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581093843","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581093843?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:00","pubTimestamp":1762434003,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nPLX29A922:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4547","BK4588","BK4139","BK4585","NVAX","BK4568"],"gpt_icon":0},{"id":"2581938520","title":"Novavax Outlook FY Adj Total Revenue $1.04 Bln-$1.06 Bln VS Ibes Estimate $1.05 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2581938520","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581938520?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:00","pubTimestamp":1762434000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nP8N3MD0LN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVAX","BK4547","BK4585","BK4588","BK4568","BK4139"],"gpt_icon":0},{"id":"2581093386","title":"Novavax: Non-Cash Charges for Q3 Were $126 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2581093386","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581093386?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:00","pubTimestamp":1762434000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nP8N3MD0LN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4568","NVAX","BK4139","BK4547","BK4588"],"gpt_icon":0},{"id":"2581098427","title":"Novavax beats quarterly revenue estimates on milestone payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2581098427","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581098427?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:55","pubTimestamp":1762433704,"startTime":"0","endTime":"0","summary":"Novavax beats quarterly revenue estimates on milestone paymentNov 6  - Novavax NVAX.O beat Wall Street expectations for third-quarter revenue on Thursday, helped by milestone payments tied to its COVID-19 vaccine partnerships.The biotech firm reported total revenue of $70.4 million, compared with analysts' average estimate of $42.13 million, according to data compiled by LSEG.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL4N3WI1CM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX","BK4139","BK4568","BK4585","BK4588","BK4547"],"gpt_icon":0},{"id":"2581098920","title":"Novavax Q3 Revenue $70.4 Mln VS Ibes Estimate $42.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2581098920","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581098920?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:48","pubTimestamp":1762433321,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nP8N3MD0LO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVAX","BK4585","BK4139","BK4547","BK4568","BK4588"],"gpt_icon":0},{"id":"2581987470","title":"Robinhood To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2581987470","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581987470?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:41","pubTimestamp":1762432860,"startTime":"0","endTime":"0","summary":"Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.\nConsidering buying HOOD stock? Here’s what analysts think: \nRead This Next: \nPhoto via Shutterstock","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/06/ChatGPT-said--Robinhood-Earnings-Soar.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/06/ChatGPT-said--Robinhood-Earnings-Soar.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/25/11/48683302/robinhood-to-rally-more-than-20-here-are-10-top-analyst-forecasts-for-thursday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/25/11/48683302/robinhood-to-rally-more-than-20-here-are-10-top-analyst-forecasts-for-thursday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["LU1861558580.USD","BK4127","BK4547","LU1861559042.SGD","HOOD","BK4539"],"gpt_icon":0},{"id":"2581600290","title":"Cantor Analyst Remains Cautious on Rivian Stock (RIVN) Despite Q3 Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=2581600290","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581600290?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:37","pubTimestamp":1762432624,"startTime":"0","endTime":"0","summary":"Electric vehicle (EV) maker Rivian Automotive ($RIVN) delivered better-than-expected results for the third quarter of 2025, driving its stock highe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/cantor-analyst-remains-cautious-on-rivian-stock-rivn-despite-q3-beat?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/cantor-analyst-remains-cautious-on-rivian-stock-rivn-despite-q3-beat?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4099","BK4588","BK4596","BK4547","RIVN","BK4555"],"gpt_icon":0},{"id":"2581306089","title":"Stagwell Shares up 60% Premarket After Co Announces AI Partnership With Palantir, Better-Than-Expected FY Profit Forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2581306089","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581306089?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:28","pubTimestamp":1762432114,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL4N3WI1AC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B894F039.SGD","BK4023","LU1861559042.SGD","BK4588","IE00BZ9MQY76.HKD","BK4547","BK4543","IE00B19Z9Z06.USD","LU1169590202.USD","LU1169589451.USD","BK4585","LU1861558580.USD","PLTR","STGW","BK4613","IE00B19Z9P08.USD","BK4009"],"gpt_icon":0},{"id":"2581067057","title":"Stagwell Q3 revenue misses estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2581067057","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581067057?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:26","pubTimestamp":1762431966,"startTime":"0","endTime":"0","summary":"Stagwell Q3 revenue misses estimatesOverviewStagwell Q3 revenue grows 4% yr/yr, slightly missing analyst expectationsAdjusted EPS for Q3 beats analyst expectationsQ3 Adjusted EBITDA of $115 mln missed","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL1N3WI0MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00B894F039.SGD","STGW","BK4009","LU1169590202.USD","LU1861558580.USD","LU1861559042.SGD","IE00B19Z9Z06.USD","BK4547","BK4588","IE00B19Z9P08.USD","BK4613","LU1169589451.USD","IE00BZ9MQY76.HKD","BK4023","BK4543"],"gpt_icon":1},{"id":"2581406721","title":"BRIEF-Palantir Technologies And Stagwell Announces Partnership Centered Around An AI-Driven Platform For Marketers","url":"https://stock-news.laohu8.com/highlight/detail?id=2581406721","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581406721?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:20","pubTimestamp":1762431643,"startTime":"0","endTime":"0","summary":"BRIEF-Palantir Technologies And Stagwell Announces Partnership Centered Around An AI-Driven Platform For MarketersNov 6 (Reuters) - Palantir Technologies Inc PLTR.O:PALANTIR TECHNOLOGIES INC -CO AND S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI16P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4547","IE00BZ9MQY76.HKD","BK4009","LU1861558580.USD","STGW","PLTR","LU1861559042.SGD","BK4023","BK4588","IE00B19Z9P08.USD","IE00B894F039.SGD","BK4543","BK4613","IE00B19Z9Z06.USD","BK4585","LU1169589451.USD","LU1169590202.USD"],"gpt_icon":0},{"id":"2581406766","title":"Stagwell Inc. reports net new business of $122 million in third quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2581406766","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581406766?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:15","pubTimestamp":1762431346,"startTime":"0","endTime":"0","summary":"Stagwell Inc. reported net new business of $122 million in the third quarter and $472 million over the last twelve months. The company achieved a 19% adjusted EBITDA margin and a 9% year-over-year increase in adjusted diluted EPS to $0.24. Stagwell highlighted double-digit growth in non-advocacy work and strong organic growth in most areas. The period also saw enhanced cash flow and increased non-advocacy margin. Stagwell announced a partnership with Palantir to advance AI applications in marketing. Management cited ongoing cost discipline and improved labor efficiency as key factors in the company's financial performance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stagwell Inc. published the original content used to generate this ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL7BX116:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","IE00B19Z9Z06.USD","STGW","BK4009","IE00B894F039.SGD","BK4023","LU1169590202.USD","BK4547","BK4543","BK4613","IE00B19Z9P08.USD","LU1861559042.SGD","LU1861558580.USD","BK4585","BK4588","IE00BZ9MQY76.HKD"],"gpt_icon":1}],"pageSize":20,"totalPage":41,"pageCount":3,"totalSize":804,"code":"91000000","status":"200"}]}}